Serial Non-Invasive Myocardial Work Measurements for Patient Risk Stratification and Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients: A Single-Centre Observational Study
暂无分享,去创建一个
J. Duchenne | M. Penicka | R. Dierckx | J. Bartunek | M. Goethals | G. Van Camp | M. Vanderheyden | W. Heggermont | S. Verstreken | D. Buytaert | A. Roelstraete | G. Huygh | P. Paolisso | A. Moya | M. Beles | Ciska Langmans
[1] W. Liu,et al. Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics–related cardiac dysfunction , 2022, BMC cardiovascular disorders.
[2] G. Boriani,et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). , 2022, European heart journal. Cardiovascular Imaging.
[3] B. Wintersperger,et al. Diagnostic and Prognostic Value of Myocardial Work Indices for Identification of Cancer Therapy-Related Cardiotoxicity. , 2022, JACC. Cardiovascular imaging.
[4] Wei Yang,et al. Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography , 2021, Frontiers in Pharmacology.
[5] D. Lenihan,et al. Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers , 2021, Circulation. Cardiovascular imaging.
[6] P. Heuschmann,et al. Impact of cardiovascular risk factors on myocardial work—insights from the STAAB cohort study , 2021, Journal of Human Hypertension.
[7] I. Ikonomidis,et al. Myocardial Work: Methodology and Clinical Applications , 2021, Diagnostics.
[8] J. Moslehi,et al. Global Longitudinal Strain in Cardio-Oncology. , 2021, Journal of the American College of Cardiology.
[9] O. Smiseth,et al. How to measure left ventricular myocardial work by pressure-strain loops. , 2020, European heart journal cardiovascular Imaging.
[10] T. Marwick,et al. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. , 2020, Journal of the American College of Cardiology.
[11] P. Lancellotti,et al. Prognostic role of global work index in asymptomatic patients with aortic stenosis , 2020 .
[12] P. Heuschmann,et al. Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study , 2020, PloS one.
[13] F. Flachskampf,et al. Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis. , 2020, European heart journal cardiovascular Imaging.
[14] C. Leclercq,et al. Prognostic Usefulness of Myocardial Work in Patients With Heart Failure and Reduced Ejection Fraction Treated by Sacubitril/Valsartan. , 2020, The American journal of cardiology.
[15] E. Oikonomou,et al. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis. , 2019, JAMA cardiology.
[16] M. Galderisi,et al. Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction. , 2019, European heart journal cardiovascular Imaging.
[17] J. Zamorano,et al. Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study. , 2019, European heart journal cardiovascular Imaging.
[18] B. Gerber,et al. Myocardial strain imaging: review of general principles, validation, and sources of discrepancies , 2019, European heart journal cardiovascular Imaging.
[19] O. Smiseth,et al. Myocardial work by echocardiography: a novel method ready for clinical testing. , 2018, European heart journal cardiovascular Imaging.
[20] K. Akashi,et al. Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity , 2018, Clinical Research in Cardiology.
[21] S. Xavier,et al. Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment , 2018, Arquivos brasileiros de cardiologia.
[22] J. Zamorano,et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study , 2017, European heart journal cardiovascular Imaging.
[23] L. Calvo,et al. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study , 2016, Clinical and Translational Oncology.
[24] Hans Torp,et al. Myocardial strain imaging: how useful is it in clinical decision making? , 2015, European heart journal.
[25] M. Cerqueira,et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2014, European heart journal cardiovascular Imaging.
[26] B. Khandheria,et al. Diagnosis of Chemotherapy-Induced Cardiotoxicity , 2014 .
[27] Jan Gunnar Fjeld,et al. A novel clinical method for quantification of regional left ventricular pressure–strain loop area: a non-invasive index of myocardial work , 2012, European heart journal.
[28] R. Russell,et al. Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment , 2011, Current cardiology reviews.
[29] R. Coombes,et al. Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.